Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zaniboni

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
World Journal of Gastrointestinal Surgery|January 6, 2016
New active drugs for the treatment of advanced colorectal cancerAlberto Zaniboni
Cancers|April 13, 2024
Sunglasses for Sunlight: Considerations on New Treatment Opportunities for Refractory Colorectal CancerAlberto Zaniboni
Recenti Progressi in Medicina|August 6, 2019
[The toxicity profile of TAS-102. Practical considerations about neutropenia.]Alberto Zaniboni
Recenti Progressi in Medicina|December 21, 2016
[Aflibercept: focus on tolerability.]Alberto Zaniboni
Recenti Progressi in Medicina|October 20, 2020
[Smell and taste in CoViD-19 patients: the forgotten sense.]Paolo Gamba, Alberto Zaniboni
Journal of Clinical Medicine|November 14, 2019
Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current LiteratureEster Oneda, Alberto Zaniboni
Recenti Progressi in Medicina|October 29, 2019
[Considerations about the importance of nutritional status in the treatment of advanced colorectal cancer.]Ester Oneda, Alberto Zaniboni
Critical Reviews in Oncology/Hematology|November 21, 2021
Adjuvant treatment of colon cancer with microsatellite instability - the state of the artEster Oneda, Alberto Zaniboni
Central Nervous System Agents in Medicinal Chemistry|January 22, 2011
Newer avenues for the treatment of leptomeningeal carcinomatosisFausto Meriggi, Alberto Zaniboni
Recenti Progressi in Medicina|January 19, 2016
[Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case]Francesca Aroldi, Alberto Zaniboni
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
World Journal of Gastrointestinal Surgery|January 6, 2016
New active drugs for the treatment of advanced colorectal cancerAlberto Zaniboni
Cancers|April 13, 2024
Sunglasses for Sunlight: Considerations on New Treatment Opportunities for Refractory Colorectal CancerAlberto Zaniboni
Recenti Progressi in Medicina|August 6, 2019
[The toxicity profile of TAS-102. Practical considerations about neutropenia.]Alberto Zaniboni
Recenti Progressi in Medicina|December 21, 2016
[Aflibercept: focus on tolerability.]Alberto Zaniboni
Recenti Progressi in Medicina|October 20, 2020
[Smell and taste in CoViD-19 patients: the forgotten sense.]Paolo Gamba, Alberto Zaniboni
Journal of Clinical Medicine|November 14, 2019
Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current LiteratureEster Oneda, Alberto Zaniboni
Recenti Progressi in Medicina|October 29, 2019
[Considerations about the importance of nutritional status in the treatment of advanced colorectal cancer.]Ester Oneda, Alberto Zaniboni
Critical Reviews in Oncology/Hematology|November 21, 2021
Adjuvant treatment of colon cancer with microsatellite instability - the state of the artEster Oneda, Alberto Zaniboni
Central Nervous System Agents in Medicinal Chemistry|January 22, 2011
Newer avenues for the treatment of leptomeningeal carcinomatosisFausto Meriggi, Alberto Zaniboni
Recenti Progressi in Medicina|January 19, 2016
[Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case]Francesca Aroldi, Alberto Zaniboni
Pageof 24